Bladder Cancer is the most common malignant tumor in urinary system, the morbidity is increasing yearly. New bladder tumor patient in worldwide is more than 300,000 per year, Top 7 in human being’s common tumor, and Top 8 in tumor deaths, which threaten to human life seriously. Bladder cancer’s recurrence rate is higher than 70% after cure, and 30% recurrence getting more worse, hence, lifelong close follow-up is needed.(BTA reagent)
Clinical Application of
diagnostic lab BTA reagent:1. Postoperative follow-up of bladder tumor2. High risk population screening3. Evaluation of treatment effect4. Auxiliary diagnosis of bladder tumorBladder Tumor Associated Antigen (BTA) Quantitative Detection Kit (ELISA) 48 tests/96 tests
If you are interested, please contact us per.service003@perlong.com.cn
没有评论:
发表评论